Murray Mark Christopher (CIK 0001800013)

Latest company ownership

Role: EVP, Biomaterials & AT
Shares held
18,680
Last filed at
Jan 18, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Role: SVP - Acetyls
Shares held
17,000
Last filed at
Aug 18, 2025
Confidence Score
56.7
2025Q4
Confidence Score History
2023Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 14, 2025 Aug 18, 2025 Celanese Corp SVP - Acetyls Buy 95.0 +2,017 13.46% $84.4K
Jul 13, 2025 Jul 15, 2025 Celanese Corp SVP - Acetyls Sell 26.3 -485 -3.14% $29.5K
May 23, 2025 May 28, 2025 Celanese Corp SVP - Acetyls Buy 95.0 +1,479 10.57% $77.2K
Mar 7, 2025 Mar 10, 2025 Celanese Corp SVP - Acetyls Buy 95.0 +2,353 20.22% $128.1K
Feb 15, 2025 Feb 19, 2025 Celanese Corp SVP - Acetyls Sell 83.8 +507 4.56% $25.2K
Jul 13, 2024 Jul 16, 2024 Celanese Corp SVP - Acetyls Sell 22.5 -471 -4.06% $66.2K
Mar 8, 2024 Mar 11, 2024 Celanese Corp SVP - Acetyls Buy 90.0 +597 5.43% $93.4K
Feb 15, 2024 Feb 20, 2024 Celanese Corp SVP - Acetyls Sell 26.3 -124 -1.11% $18.7K
Jul 13, 2023 Jul 17, 2023 Celanese Corp SVP - Acetyls Sell 22.5 -470 -4.05% $57.4K
May 12, 2023 May 15, 2023 Celanese Corp SVP - Acetyls Buy 90.0 +1,008 9.52% $102.5K
Feb 28, 2023 Mar 2, 2023 Celanese Corp SVP - Acetyls Buy 95.0 +1,200 12.78% $140.6K
Feb 15, 2023 Feb 17, 2023 Celanese Corp SVP - Acetyls Sell 26.3 -124 -1.30% $15.1K
Jan 13, 2022 Jan 18, 2022 Avantor, Inc. EVP, Biomaterials & AT Sell 46.3 -918 -4.68% $34.4K
Jan 13, 2021 Jan 15, 2021 Avantor, Inc. EVP, Biomaterials & AT Sell 46.3 -918 -7.42% $26.8K